FDA approves intravenous peramivir for treatment of seriously ill H1N1 patients
The Food and Drug Administration (FDA) has issued an emergency use authorization for intravenous (IV) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection.
Specifically, IV peramivir is authorized only for hospitalized adult and pediatric patients for whom therapy with an IV drug is clinically appropriate, based on one or more of the following reasons:
The patient is not responding to either oral or inhaled antiviral therapy, or
When drug delivery by a route other than an intravenous route — e.g., enteral (absorbed by the intestines) or inhaled — is not expected to be dependable or feasible;
For adults only, when the clinician judges IV therapy is appropriate due to other circumstances.
Whether it's your first year on the job or your 20th, J. J. Keller's Workplace Safety Pro Manual gives you the tools you need to create and maintain a safe and compliant workplace.
This handy resource outlines the goals and objectives of a workplace safety program and provides the blueprint for building it. Already have a safety program? The manual shows you how to comply by using proven best-practices and how to stay in compliance by introducing solid, easy-to-use safety management practices.
J. J. Keller's FREE Transportation SafetyClicks™ e-mail newsletter brings quick-read safety and compliance news right to your e-mail box.
